Zivo Bioscience Reports Director/Officer Changes & Financials
Ticker: ZIVOW · Form: 8-K · Filed: Dec 23, 2025 · CIK: 1101026
| Field | Detail |
|---|---|
| Company | Zivo Bioscience, Inc. (ZIVOW) |
| Form Type | 8-K |
| Filed Date | Dec 23, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $27,040, $7.96, $285.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, financial-reporting
TL;DR
ZIVO's 8-K: New directors/officers appointed, financials filed. Leadership shakeup incoming?
AI Summary
Zivo Bioscience, Inc. filed an 8-K on December 23, 2025, reporting events as of December 19, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates potential shifts in the company's leadership and financial reporting, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with financial statement filings, can signal significant internal shifts or financial health updates that warrant closer investor scrutiny.
Key Players & Entities
- Zivo Bioscience, Inc. (company) — Registrant
- December 19, 2025 (date) — Earliest event reported
- December 23, 2025 (date) — Date of report
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, but the specific names and details are not provided in this excerpt.
What type of financial statements were filed?
The filing states that 'Financial Statements and Exhibits' were filed, but the specific nature or period of these statements is not detailed in this excerpt.
What is the company's state of incorporation and fiscal year end?
Zivo Bioscience, Inc. is incorporated in Nevada and its fiscal year ends on December 31.
What is the company's SIC code and industry?
The company's Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (no diagnostic substances).
What were the former names of Zivo Bioscience, Inc.?
The company was formerly known as Health Enhancement Products Inc. (name change on 20040202) and Western Glory Hole Inc. (name change on 19991215).
Filing Stats: 1,055 words · 4 min read · ~4 pages · Grade level 10.7 · Accepted 2025-12-23 16:06:03
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ZIVO OTCQB Warrants to p
- $27,040 — titled to receive his present salary of $27,040 per month until December 31, 2026. Mr.
- $7.96 — of the Company at an exercise price of $7.96 per share, which will be exercisable un
- $285.00 — independent contractor and will receive $285.00 per hour worked. The Services Agreement
Filing Documents
- zivo_8k.htm (8-K) — 31KB
- zivo_ex101.htm (EX-10.1) — 32KB
- zivo_ex102.htm (EX-10.2) — 62KB
- 0001654954-25-014296.txt ( ) — 282KB
- zivo-20251219.xsd (EX-101.SCH) — 5KB
- zivo-20251219_lab.xml (EX-101.LAB) — 15KB
- zivo-20251219_cal.xml (EX-101.CAL) — 1KB
- zivo-20251219_pre.xml (EX-101.PRE) — 11KB
- zivo-20251219_def.xml (EX-101.DEF) — 5KB
- zivo_8k_htm.xml (XML) — 5KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Separation Agreement, dated December 19, 2025, between Zivo Bioscience, Inc. and Keith R. Marchiando 10.2 Independent Contractor Services Agreement, dated December 19, 2025, between Zivo Bioscience, Inc. and William A. Sullivan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZIVO BIOSCIENCE, INC. By: /s/ John Payne John Payne Chief Executive Officer Date: December 23, 2025 3